USD $36.36
CAFCIT Syrup is a specially formulated caffeine citrate solution used primarily to treat certain medical conditions in newborns, such as apnea of prematurity. This condition involves breathing pauses in premature infants, and CAFCIT Syrup acts as a central nervous system stimulant to help reduce these episodes.
CAFCIT Syrup works by stimulating the central nervous system. It increases the breathing rate and heart rate, thereby reducing the number of apnea episodes in premature infants. This allows for improved oxygenation and overall stability in infants with breathing difficulties.
CAFCIT Syrup is intended for use in premature infants diagnosed with apnea of prematurity. It should only be administered under the guidance and supervision of a healthcare professional. Always consult with a pediatrician or neonatologist before using this product.
Administration of CAFCIT Syrup should follow the prescribed dosage by a healthcare provider. Typically, it is given orally using a dropper or syringe provided with the medication. The dosing schedule and quantity are determined based on the infant's weight and medical condition.
Before using CAFCIT Syrup, inform the healthcare provider of any medical history or other medications the infant is taking. Monitoring the infant's response to the medication is crucial, and any adverse reactions should be reported immediately. Keep the syrup out of reach of children and store it as directed by the manufacturer.
While CAFCIT Syrup is generally well-tolerated, some infants may experience side effects such as irritability, increased heart rate, or gastrointestinal disturbances. If any severe side effects occur, contact a healthcare professional promptly.
For more information about CAFCIT Syrup, including detailed usage instructions and safety information, please consult with a healthcare provider or refer to the product's official documentation provided by the manufacturer.
Health Guides